APL-4098

· Apollo Therapeutics Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for APL-4098, covering 2026-02-04 to 2026-02-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS [Phase 1]